Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Bio-IT World Announces 2019 Best Of Show People's Choice Award Contenders

    Apr 10, 2019, 10:05 AM by Michael Croft

    Bio-IT World | Bio-IT World is pleased to announce the 2019 Best of Show competition with the Bio-IT World People’s Choice award.

    Full story
  • CluePoints Experiences Continued Rapid Growth as Demand for RBx Rises

    Apr 9, 2019, 10:37 AM by Michael Croft
    WAYNE, PA - Apr 9, 2019 - CluePoints, a leading provider of Risk-Based Study Execution (RBx) and Data Quality Oversight solutions for clinical trials, has announced a progressive outlook of continued and significant global growth and continued investment in people and technology throughout North America, Europe and Asia Pacific
    Full story
  • Resolution Liquid Biopsy Assay Demonstrates Fewer False Positives and Higher Positive Predictive Value Than Three Known Commercial ctDNA NGS Tests

    Apr 9, 2019, 10:03 AM by Michael Croft
    KIRKLAND, WA, UNITED STATES - Apr 9, 2019 - Resolution Bioscience, Inc., today announced that a team of AstraZeneca scientists recently published results of a study looking at assay discordance and technical variations between four leading commercial next-generation sequencing (NGS) gene panels
    Full story
  • Avellino Labs Welcomes James (Jim) V. Mazzo to Its Board of Directors

    Apr 9, 2019, 07:09 AM by Michael Croft
    MENLO PARK, CA, UNITED STATES - Apr 9, 2019 - Avellino Labs, global biotechnology and genetic science innovators, announced the strategic addition of James (Jim) V
    Full story
  • MDI Biological Laboratory to Hold Panel Discussion on the Opioid Crisis in Maine

    Apr 8, 2019, 13:50 PM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Apr 8, 2019 - BAR HARBOR, MAINE -- The MDI Biological Laboratory and the University of New England (UNE) are bringing Maine researchers together to discuss how they can collaborate to identify solutions to the opioid epidemic in Maine
    Full story
  • Life Science Integrates launches new Bio Integrates to address the biggest challenges impacting the pharma and biotech sector

    Apr 8, 2019, 11:20 AM by Michael Croft
    LONDON, UK - Apr 1, 2019 - Inspired by the success of Pharma Integrates, Life Science Integrates has introduced the new Bio Integrates conference, to be held at the Grange Tower Bridge Hotel, London, on the 22ndMay 2019
    Full story
  • How Artificial Intelligence Will Impact Drug Development

    Apr 8, 2019, 10:10 AM by Michael Croft

    Bio-IT World | Artificial intelligence has the potential to stimulate and streamline drug discovery and development by increasing our understanding of complex biology, guiding drug design, and by assisting other more mundane elements of pharmaceutical R&D and regulatory affairs.

    Full story
  • Quantabio Launches Single-Tube Lyophilized Reagent to Simplify Shipping, Storage and Setup of RT-qPCR RNA Applications

    Apr 8, 2019, 09:55 AM by Michael Croft
    BEVERLY, MA, UNITED STATES - Apr 8, 2019 - Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today launched the Qscript lyo 1-step, a lyophilized single-reaction reagent optimized for highly sensitive and reproducible RT-qPCR RNA applications
    Full story
  • HLA Typing With PacBio Shown To Improve Transplant Outcomes

    Apr 5, 2019, 08:05 AM by Michael Croft

    Bio-IT World News Brief | Scientists at the Anthony Nolan Research Institute in the UK have demonstrated that ultra-high-resolution HLA typing performed with PacBio sequencing identified stronger matches associated with improved survival rates among patients who received hematopoietic stem cell transplants. The retrospective study was published this week in the Journal of Biology of Blood and Marrow Transplantation.

    Full story
  • Greenphire Launches New Tax Capability to Ease Administrative Burden and Improve Compliance for Clinical Trial Industry

    Apr 4, 2019, 15:55 PM by Michael Croft
    KING OF PRUSSIA, PA, UNITED STATES - Apr 4, 2019 - Greenphire, the global leader in financial software for clinical trials, announced today that it has released a new tax capability for its customers, easing the administrative burden of reporting, tracking, and managing tax associated with participant payments
    Full story
  • Data Visualization's Use In A Data-Driven World

    Apr 4, 2019, 09:25 AM by Michael Croft

    Bio-IT World | As medicine becomes frequently data-driven, data visualization will be key to the progress of its various fields.

    Full story
  • WCG Announces the Acquisition of Analgesic Solutions, LLC

    Apr 4, 2019, 08:48 AM by Michael Croft
    PRINCETON, NJ - Apr 4, 2019 - The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announces the acquisition of Analgesic Solutions, LLC, the global leader in the development of new pain medications and in the support of clinical trials in which pain is an indicator of an underlying condition
    Full story
  • Medacta Opens IPO-Season 2019 at SIX

    Apr 4, 2019, 04:42 AM by Michael Croft
    ZURICH, SWITZERLAND - Apr 4, 2019 - Today, the shares of Medacta Group SA (ticker "MOVE") were traded for the first time at SIX, opening at CHF 104x
    Full story
  • Discovery Life Sciences Acquires HudsonAlpha Genomic Services Lab

    Apr 3, 2019, 07:35 AM by Michael Croft

    Bio-IT World News Brief | Discovery Life Science has acquired the assets, technology and staff of the HudsonAlpha Genomic Services Laboratory (GSL). Financial terms were not disclosed, but the HudsonAlpha Institute is now a shareholder of Discovery Life Sciences.

    Full story
  • Strata Oncology Launches Expanded StrataNGS for Patients with Advanced Cancer

    Apr 2, 2019, 13:32 PM by Michael Croft
    BELFORD, NJ, US - Apr 1, 2019 - Strata Oncology Launches Expanded StrataNGS for Patients with Advanced CancerUpdated StrataNGS test analyzes 500 cancer genes and reports status for three key immunotherapy biomarkers to inform the use of precision therapiesANN ARBOR, Mich
    Full story
  • Australia: Moratorium On Genetic Test Results To Be Binding Life Industry Standard

    Apr 2, 2019, 12:25 PM by Michael Croft

    Asia Insurance Review | From 1 July 2019, the Financial Services Council (FSC) will enact the moratorium on life insurance genetic test results as a binding standard, following stakeholder feedback on the FSC Life Insurance Code of Practice consultation.

    Full story
  • CRF Bracket Industry Experts to Host Educational Seminar on Patient-First Technology in Clinical Trials

    Apr 2, 2019, 09:55 AM by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Apr 2, 2019 -   CRF Bracket will host a complimentary half-day educational seminar on April 24th in Cambridge, MA, to share industry insights on patient-first technology in clinical trials
    Full story
  • Mologic expands US and UK operations

    Apr 2, 2019, 08:28 AM by Michael Croft
    BEDFORDSHIRE, UNITED KINGDOM - Apr 1, 2019 -
    • Strengthens team as part of continued international expansion
    • Bolsters US presence with the opening of subsidiary in Boston, MA
    • Doubles device manufacturing capacity in UK
    Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, services and products, today announced it has completed the latest phase of the Company's expansion plans
    Full story
  • Sterling Pharma Solutions announces acquisition of CiVentiChem in the US

    Apr 2, 2019, 05:20 AM by Michael Croft
    NEWCASTLE, UK - Apr 2, 2019 - UK-based contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of CiVentiChem’s US facility located in Cary, North Carolina, US
    Full story
  • ChargePoint Technology Launches Single Use Technology as part of Powder Transfer Solutions portfolio at INTERPHEX 2019

    Apr 2, 2019, 04:23 AM by Michael Croft
    - Apr 1, 2019 - Contained and sterile transfer solutions expert, ChargePoint Technology today announces new, single use additions to its portfolio; the ChargePoint® Single Use Passive (SUP) and ChargeBag® PE-S with new HiPure ULP7 PE film
    Full story
  • «
  • 241
  • 242 (current)
  • 243
  • 244
  • 245
  • 246
  • 247
  • 248
  • 249
  • 250
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy